Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-04 @ 4:43 PM
Study NCT ID:
NCT05751668
Status:
RECRUITING
Last Update Posted:
2025-08-05
First Post:
2023-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-03-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-21
First Submit QC Date:
None
Study First Post Date:
2023-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-04
Last Update Post Date:
2025-08-05
Last Update Post Date Type:
ACTUAL